Jallal Bahija
CIK 0001730038
CHIEF EXECUTIVE OFFICERDirector
Filings
10
Latest May 15, 2026
Issuers covered
4
Showing
10 of 10
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +8.0% | +8.0% | +8.0% | +8.0% |
| 90 days | 1 | 100% | +11.0% | +11.0% | +11.0% | +11.0% |
| 180 days | - | - | - | - | - | - |
| 365 days | - | - | - | - | - | - |
Issuers
Companies where Jallal Bahija has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ELV | Elevance Health, Inc. | 5 | May 15, 2026 |
| IMCR | Immunocore Holdings PLC | 3 | Feb 19, 2026 |
| AVBP | Arrivent Biopharma, Inc. | 1 | Jan 29, 2024 |
| GH | Guardant Health, Inc. | 1 | Jun 17, 2022 |
All filings
10 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|